Madrigal Pharmaceuticals Inc (MDGL)

NASDAQ · Biotechnology

515.81
-9.06 (-1.73%)
Updated Aug 18, 5:45 PM ET
AI Rating
Hold
Overall Score
53
Trend
68
Momentum
38
Risk
50

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 19, 2026 120 sessions Aug 14, 2026

AI Analysis

Madrigal Pharmaceuticals Inc is trading at $515.81, down 1.73% on the session. The 50 day average sits at $515.64 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 45.1, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $501.21 with resistance near $535.76, so that band frames the current range. Average daily movement is roughly $23.73, or about 4.6% of the share price, which is what any stop placement has to allow for. The overall health score of 53 out of 100 combines a trend score of 68, momentum of 38 and a risk score of 50.

Technical indicators

RSI (14)
45.1
neutral
MACD
-3.063
bearish crossover
SMA 20
526.43
SMA 50
515.64
SMA 200
--
unknown
ATR (14)
23.73
avg daily range
Support
501.21
Resistance
535.76
Volume vs 20d
0.64x
below average
Volatility
53.6%
annualised
1 month
-4.41%
3 months
+2.12%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.